Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - fingolimodum - capsule rigide - fingolimodum 0.5 mg ut fingolimodi hydrochloridum, calcii hydrogenophosphas dihydricus, glycinum, silica colloidalis anhydrica, magnesii stearas, kapselhülle: e 171, gelatina, e 172 (rubrum), e 172 (flavum), drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula. - multiple sklerose - synthetika

Den Europæiske Union - italiensk - EMA (European Medicines Agency)

novartis europharm limited - imatinib - precursor cell lymphoblastic leukemia-lymphoma; gastrointestinal stromal tumors; dermatofibrosarcoma; myelodysplastic-myeloproliferative diseases; leukemia, myelogenous, chronic, bcr-abl positive; hypereosinophilic syndrome - agenti antineoplastici - glivec is indicated for the treatment of , adult and paediatric patients with newly diagnosed philadelphia-chromosome (bcr-abl)-positive (ph+) chronic myeloid leukaemia (cml) for whom bone-marrow transplantation is not considered as the first line of treatment;, adult and paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis;, adult and paediatric patients with newly diagnosed philadelphia-chromosome-positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy;, adult patients with relapsed or refractory ph+ all as monotherapy;, adult patients with myelodysplastic / myeloproliferative diseases (mds / mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements;, adult patients with advanced hypereosinophilic syndrome (hes) and / or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfra rearrangement. l'effetto di glivec sull'esito del midollo osseo trapianto non è stata determinata. glivec is indicated for: , the treatment of adult patients with kit (cd 117)-positive unresectable and / or metastatic malignant gastrointestinal stromal tumours (gist);, the adjuvant treatment of adult patients who are at significant risk of relapse following resection of kit (cd117)-positive gist. i pazienti che hanno un basso o bassissimo rischio di recidiva non dovrebbero ricevere il trattamento adiuvante; il trattamento dei pazienti adulti con metastasi dermatofibrosarcoma protuberans (dfsp) e in pazienti adulti con recidivante e / o metastatico dfsp che non sono eleggibili per la chirurgia. in pazienti adulti e pediatrici, l'efficacia di glivec è basato sulla complessiva ematologica e citogenetica tassi di risposta e di sopravvivenza libera da progressione in cml, ematologica e citogenetica tassi di risposta ph+, mds / mpd, su valori di risposta ematologica in hes / lec e su tassi di risposta obiettiva in pazienti adulti con operabili e / o metastatici gist e dfsp e la sopravvivenza libera da recidiva in adiuvante gist. l'esperienza con glivec in pazienti con mds / mpd associate a riarrangiamenti del gene pdgfr è molto limitata (vedere la sezione 5. tranne che nel recente diagnosi di lmc in fase cronica, non ci sono studi clinici controllati che dimostrano un beneficio clinico o un aumento della sopravvivenza per queste malattie.

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - mesuximidum - capsule - mesuximidum 300 mg, colore.: di e 104, e 110, excipiens per la capsula. - antiepilepticum - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

grünenthal pharma ag - tramadoli hydrochloridum - capsule - tramadoli hydrochloridum 50 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, aqua, natrii laurilsulfas, e 172 (flavum), e 171, pro capsula corresp. natrium max. 0.9 mg. - analgesico - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - isotretinoinum - capsule - isotretinoinum 10 mg, cera flava, sojae oleum hydrogenatum 7.68 mg, sojae oleum partim hydrogenatum 30.72 mg, sojae oleum raffinatum 107.92 mg, kapselhülle: gelatina, glycerolum (85 per centum), sorbitolum 3.05 mg, mannitolum, amylum hydrolysatum hydrogenatum, e 171, e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, pro capsula. - gravi intrattabile, forme di acne - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - isotretinoinum - capsule - isotretinoinum 20 mg, cera flava, sojae oleum hydrogenatum 15.36 mg, sojae oleum partim hydrogenatum 61.44 mg, sojae oleum raffinatum 215.84 mg, kapselhülle: gelatina, glycerolum (85 per centum), sorbitolum 4.86 mg, mannitolum, amylum hydrolysatum hydrogenatum, e 171, e 172 (rubrum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, pro capsula. - gravi intrattabile, forme di acne - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - tizanidinum - a rilascio prolungato capsule. - tizanidinum 6 mg ut tizanidini hydrochloridum, maydis amylum, saccharum 124.3-142.2 mg, aqua purificata, ethylcellulosum, lacca, talcum, gelatina, e 171, e 172 (nigrum), pro capsula. - myotonolyticum - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - acido mefenamicum - capsule - acidum mefenamicum 250 mg, polysorbatum 80, carmellosum natricum conexum, cellulosum microcristallinum, povidonum k 25, acidum stearicum, kapselhülle: gelatina, pro capsula corresp. natrium 50.6 µg. - antirheumaticum, analgeticum - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

antistress aktiengesellschaft für gesundheitsschutz - betacarotenum - burgerstein beta-carotene-6 mg kapseln - betacarotenum 6.28 mg ut carotenoida nativa, sojae oleum 157.66 mg, ethanolum 0.50 mg, e 306, e 307, oleum vegetabile, sojae oleum raffinatum 0.51 mg, kapselhülle: gelatina, glycerolum (85 per centum), pro capsula. - vitamina a-prodotto - synthetika

Schweiz - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - tramadoli hydrochloridum - capsule - tramadoli hydrochloridum 50 mg, cellulosum microcristallinum, carboxymethylamylum natricum a, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, aqua, natrii laurilsulfas, e 172 (flavum), e 171, pro capsula corresp. natrium max. 0.9 mg. - analgesico - synthetika